UiPath’s management acknowledged that current per‑platform unit pricing slows adoption; they plan to transition to AI credits / outcome‑based pricing (Q4 FY26 earnings). A licensing shift would remove a key friction point, enabling faster upselling to Fortune 500 clients and boosting consumption‑based revenue, potentially accelerating RPO and NDR growth. If UiPath successfully flattens revenue lumpiness with standardized vertical “AI Playbooks” and more flexible pricing, the stock could re‑rate higher as the market recognizes a sustainable growth trajectory. Execution risk on pricing transition; competition from larger AI platform players; DoD deals may be lumpy; top comment indicates bag‑holders wanting to exit, suggesting weak near‑term momentum.
UiPath’s management acknowledged that current per‑platform unit pricing slows adoption; they plan to transition to AI credits / outcome‑based pricing (Q4 FY26 earnings). A licensing shift would remove a key friction point, enabling faster upselling to Fortune 500 clients and boosting consumption‑based revenue, potentially accelerating RPO and NDR growth. If UiPath successfully flattens revenue lumpiness with standardized vertical “AI Playbooks” and more flexible pricing, the stock could re‑rate higher as the market recognizes a sustainable growth trajectory. Execution risk on pricing transition; competition from larger AI platform players; DoD deals may be lumpy; top comment indicates bag‑holders wanting to exit, suggesting weak near‑term momentum.